Causes of death in patients with myelodysplastic syndrome and spliceosome mutations
Leuk Res
.
2024 Dec:147:107612.
doi: 10.1016/j.leukres.2024.107612.
Epub 2024 Nov 6.
Authors
Panayiotis D Kontoyiannis
1
,
Arjun S Peddireddy
1
,
Koji Sasaki
2
,
Kelly Chien
2
,
Jayastu Senapati
2
,
Guillermo Montalban-Bravo
2
,
Courtney DiNardo
2
,
Gautam Borthakur
2
,
Rashmi Kanagal-Shamanna
3
,
Carlos Bueso-Ramos
3
,
Sherry Pierce
2
,
Hagop Kantarjian
2
,
Guillermo Garcia-Manero
2
,
Samuel Urrutia
4
Affiliations
1
McGovern Medical School, Houston, TX, USA.
2
Department of Leukemia MD Anderson Cancer Center, Houston, TX, USA.
3
Department of Hematopathology, MD Anderson Cancer Center, Houston, TX, USA.
4
Division of Oncology, Washington University in St Louis, MO, USA. Electronic address: surrutia@wustl.edu.
PMID:
39536685
DOI:
10.1016/j.leukres.2024.107612
No abstract available
Keywords:
Mortality; Myelodysplastic syndrome; Spliceosome mutations.
Publication types
Letter